Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$3.78 - $5.18 $736,846 - $1.01 Million
-194,933 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$4.1 - $5.33 $287,918 - $374,293
-70,224 Reduced 26.48%
194,933 $844,000
Q1 2021

May 13, 2021

BUY
$4.93 - $7.15 $1.23 Million - $1.78 Million
249,478 Added 1591.16%
265,157 $1.34 Million
Q4 2020

Feb 16, 2021

BUY
$4.55 - $7.29 $16,229 - $26,003
3,567 Added 29.45%
15,679 $99,000
Q3 2020

Nov 12, 2020

SELL
$4.22 - $6.04 $3,848 - $5,508
-912 Reduced 7.0%
12,112 $53,000
Q2 2020

Aug 13, 2020

BUY
$3.76 - $8.01 $12,874 - $27,426
3,424 Added 35.67%
13,024 $76,000
Q1 2020

May 14, 2020

SELL
$3.5 - $8.51 $18,903 - $45,962
-5,401 Reduced 36.0%
9,600 $42,000
Q4 2019

Feb 14, 2020

SELL
$4.52 - $7.91 $45,407 - $79,463
-10,046 Reduced 40.11%
15,001 $102,000
Q3 2019

Nov 14, 2019

SELL
$4.91 - $9.31 $97,345 - $184,580
-19,826 Reduced 44.18%
25,047 $122,000
Q2 2019

Aug 14, 2019

SELL
$7.08 - $10.6 $566,244 - $847,766
-79,978 Reduced 64.06%
44,873 $329,000
Q1 2019

May 15, 2019

BUY
$7.67 - $9.96 $838,292 - $1.09 Million
109,295 Added 702.59%
124,851 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$6.59 - $11.28 $75,567 - $129,347
-11,467 Reduced 42.43%
15,556 $122,000
Q3 2018

Dec 21, 2021

BUY
$9.35 - $12.44 $29,424 - $39,148
3,147 Added 13.18%
27,023 $291,000
Q3 2018

Nov 14, 2018

SELL
$9.35 - $12.44 $7,339 - $9,765
-785 Reduced 3.18%
23,876 $256,000
Q2 2018

Apr 21, 2020

BUY
$9.11 - $28.88 $32,714 - $103,708
3,591 Added 17.04%
24,661 $287,000
Q2 2018

Aug 14, 2018

BUY
$9.11 - $28.88 $48,938 - $155,143
5,372 Added 34.22%
21,070 $245,000
Q1 2018

May 15, 2018

BUY
$14.18 - $35.6 $220,470 - $553,508
15,548 Added 10365.33%
15,698 $405,000
Q4 2017

Feb 14, 2018

SELL
$4.52 - $13.69 $903 - $2,738
-200 Reduced 57.14%
150 $2,000
Q3 2017

Nov 14, 2017

BUY
$3.19 - $5.1 $1,116 - $1,784
350
350 $1,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.